Nexcelom Bioscience Cellometer K2 Evaluation AgreementEvaluation Agreement • May 12th, 2014 • Massachusetts
This Evaluation Agreement (“Agreement”) dated as of , between Nexcelom Bioscience LLC, whose business address is 360 Merrimack Street, Building 9, Lawrence, MA 01843, a limited liability company organized under the laws of Massachusetts (“Nexcelom”), and
PSS®E Evaluation AgreementEvaluation Agreement • November 7th, 2019
Your Company (hereinafter Recipient), wishes to receive an evaluation copy of Siemens Industry, Inc., Siemens Power Technologies International (hereinafter Siemens PTI) program in order to evaluate the Program's suitability for its purposes. This agreement covers the following Siemens PTI Software:
Evaluation AgreementEvaluation Agreement • June 2nd, 2022 • Massachusetts
This Evaluation Agreement (the “Agreement”) governs the use of the Mimecast Services for evaluation purposes unless a separate written agreement has been agreed with Mimecast for the purposes of evaluation of services, in which case such agreement will prevail.
Evaluation AgreementEvaluation Agreement • October 30th, 2023
This Evaluation Agreement (the “Agreement”) governs the use of the Mimecast Services for evaluation purposes unless a separate written agreement has been agreed with Mimecast for the purposes of evaluation of services, in which case such agreement will prevail.
EVALUATION AGREEMENT VEGETABLE PREFERENCE SURVEYEvaluation Agreement • August 4th, 2020
The purpose of this document is to clearly state the intent and format of the program surveys that FoodCorps members will be conducting with sample student groups in participating schools, school districts, or partner organizations and to confirm the approval of the school, school district, or partner organization to conduct this evaluation during the current program or school year.
EVALUATION AGREEMENTEvaluation Agreement • September 27th, 2022 • Massachusetts
THIS PRODUCT CONTAINS COMPUTER PROGRAMS AND OTHER PROPRIETARY MATERIAL AND INFORMATION, THE USE OF WHICH IS SUBJECT TO AND EXPRESSLY CONDITIONED UPON ACCEPTANCE OF THIS EVALUATION AGREEMENT (THE “AGREEMENT”).
EVALUATION AGREEMENTEvaluation Agreement • December 26th, 2022
THIS EVALUATION CONFIRMATION (this Agreement ) is made and entered into as of the date identified as the Effective Date below, by and between PURE STORAGE, INC. a Delaware corporation having a principal place of business at 650 Castro Street, Mountain View, CA 94041 ( Pure Storage or Pure ), and the legal entity identified below as End User or Customer . Capitalized terms not otherwise defined in this cover section document have the meaning set forth in the Pure Evaluation Agreement
CYTEL XACT PORTFOLIO EVALUATION AGREEMENTEvaluation Agreement • April 24th, 2020 • Massachusetts
BYACCESSING AND/OR USING THE SOFTWARE (EACH AS DEFINED BELOW) SELECTED IN THE ORDERING PROCESS AND LICENSED BY CYTEL INC. (“CYTEL”), YOU ARE AGREEING ON BEHALF OF THE ENTITY ACCESSING AND USING THE SOFTWARE ("COMPANY") THAT COMPANY WILL BE BOUND BY, AND HAS BECOME A PARTY TO THIS CYTEL EVALUATION AGREEMENT ("AGREEMENT") AND THAT YOU HAVE THE AUTHORITY TO BIND COMPANY. IF COMPANY DOES NOT AGREE TO ALL OF THE TERMS OF THIS AGREEMENT, DO NOT SELECT THE "I HAVE READ AND AGREED TO THE CYTEL EVALUATION AGREEMENT" BOX AND DO NOT ACCESS OR USE THE SOFTWARE. COMPANY IS NOT AUTHORIZED TO ACCESS OR USE THE SOFTWARE UNLESS AND UNTIL IT HAS AGREED TO BE BOUND BY THESE TERMS. THE "EFFECTIVE DATE" FOR THIS AGREEMENT SHALL BE THE DAY YOU CLICK THE "I HAVE READ AND AGREED TO THE CYTEL EVALUATION AGREEMENT " BOX OR ACCESS AND/OR USE THE SOFTWARE. CUSTOMER AND CYTEL ARE EACH A PARTY TO THIS AGREEMENT.
first amended and restated Evaluation AGREEMENT BY AND BETWEEN FIBROGEN, INC. AND FORTIS Therapeutics, INC. JUNE 6, 2024Evaluation Agreement • August 6th, 2024 • Fibrogen Inc • Pharmaceutical preparations • Delaware
This First Amended and Restated Evaluation Agreement (this “Agreement”) is entered into as of June 6, 2024 (the “Restatement Effective Date”) by and between FIBROGEN, INC., a Delaware corporation, with its principal place of business at 409 Illinois Street, San Francisco, California 94158 (“FibroGen”), and FORTIS THERAPEUTICS, INC., having an address at 11099 North Torrey Pines Road, Suite 290, La Jolla, CA 92037 (“Fortis”). FibroGen and Fortis may be referred to herein individually as a “Party”, or collectively as the “Parties”.
ExtremeCloud™ IQ Evaluation AgreementEvaluation Agreement • January 19th, 2022 • California
This is a trial evaluation agreement (“Agreement”) between You and Extreme Networks, Inc. and its affiliates, including Extreme Networks Ireland Ops Limited (collectively “Extreme”), regarding your use of the ExtremeCloud™ IQ Service (“Cloud Service”).
Evaluation AgreementEvaluation Agreement • May 30th, 2022
This evaluation agreement (“the Evaluation Agreement”) between Octopus Cloud AG, Baarerstrasse 145, CH-6300 Zug, Switzerland (Octopus Cloud) and the Customer is entered on the Effective Date (see below). Octopus Cloud and Customer each are a Party to this Evaluation Agreement and together are referred to as the Parties.
QBC ParaLens AdvanceTM Evaluation AgreementEvaluation Agreement • December 12th, 2013
The 30-day evaluation period begins on the date of delivery of the evaluation system. Under certain circumstances, Drucker Diagnostics may offer an extension to this period. Requests for extension must be submitted in writing (including email) before the expiration of the evaluation period, and approved by Drucker Diagnostics to be considered valid.
AGREEMENT FOR EVALUATION OF PRODUCTSEvaluation Agreement • January 9th, 2013
Datalogics, Inc., an Illinois corporation located at 101 N. Wacker Drive, Suite 1800, Chicago, IL USA 60606 (“Datalogics”) agrees to furnish the Software listed below (“Software”) under the terms and conditions hereinafter set forth:
QBC STARTM Evaluation AgreementEvaluation Agreement • May 2nd, 2014
The 30-day evaluation period begins on the date of delivery of the evaluation unit. Under certain circumstances, Drucker Diagnostics may offer an extension to this period. Requests for extension must be submitted in writing (including email) before the expiration of the evaluation period, and approved by Drucker Diagnostics to be considered valid.
Agreement The following is agreed for evaluation of PDCCHEvaluation Agreement • October 21st, 2021
According to the evaluation scenario (e.g., at FR1 in urban macro / at FR1 in indoor hotspot / at FR2 in indoor hotspot), one of three Tables (Table A.3-1 ~ A.3-3) of 38.824 can be a baseline of EVM for Rel-17 FeMIMO item 2a.
ContractEvaluation Agreement • March 30th, 2015 • MultiVir Inc. • Pharmaceutical preparations • New Jersey
EVALUATION AGREEMENTEvaluation Agreement • April 18th, 2011 • Accelr8 Technology Corp • Laboratory analytical instruments • California
This Evaluation Agreement (the “Agreement”) is made by and between Novartis Vaccines and Diagnostics, Inc., 4560 Horton Street, Emeryville, California 94608 (“Novartis Diagnostics”), and Accelr8 Technology Corporation, a corporation having its address at 7000 North Broadway, Building 3-307, Denver, Colorado 80221 (“Accelr8”), effective as of 14 June, 2010 (“Effective Date”), as follows:
EVALUATION AGREEMENT AND KNOW-HOW TRANSFEREvaluation Agreement • August 27th, 2022 • California
EVALUATION AGREEMENTEvaluation Agreement • August 1st, 2019
THIS EVALUATION AGREEMENT is by and between Unravel Data Systems, Inc., a Delaware corporation with an address at 3000 El Camino Real, Building 2, Suite 120, Palo Alto, CA 94306, on behalf of itself and its affiliates (collectively, “Unravel”), and the Customer. This Agreement is effective immediately upon the earlier of your acceptance hereof or the date that you first access or use the Software (the “Effective Date”).
TECH SOFT 3D – EVALUATION AGREEMENTEvaluation Agreement • April 26th, 2021 • California
IMPORTANT – PLEASE CAREFULLY READ THE TERMS OF THIS EVALUATION AGREEMENT (THE “AGREEMENT”) FOR THE TECH SOFT 3D PRODUCTS AND OTHER PRODUCTS TECH SOFT 3D IS AUTHORIZED TO RESELL, AND MAY INCLUDE ASSOCIATED MEDIA, PRINTED MATERIALS AND “ONLINE” OR ELECTRONIC DOCUMENTATION (COLLECTIVELY, THE “TS3D PRODUCT”). THIS IS A LEGAL AGREEMENT THAT APPLIES TO THE USE OF THE TS3D PRODUCT. BY CLICKING ON THE “I AGREE” BUTTON, CREATING A USER ACCOUNT, OR ACCESSING OR USING THE TS3D PRODUCT, (1) YOU ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTAND, AND AGREE TO BE BOUND BY THIS AGREEMENT (INCLUDING ALL OF THE TERMS AND CONDITIONS SPECIFIED OR REFERENCED BELOW), (2) YOU REPRESENT THAT YOU HAVE THE AUTHORITY TO ENTER INTO THIS AGREEMENT (INCLUDING ALL OF THE TERMS AND CONDITIONS SPECIFIED OR REFERENCED BELOW), ON BEHALF OF THE ENTITY OR PERSON WHO REGISTERED A USER ACCOUNT TO ACCESS AND USE THE TS3D PRODUCT (SUCH ENTITY OR PERSON, “EVALUATOR”), AND TO BIND EVALUATOR TO THE TERMS OF THIS AGREEMENT, AND (3) YOU
EVALUATION FORM AGREEMENTEvaluation Agreement • January 10th, 2018
This Evaluation Agreement (the “Agreement”) is made, by and between Nyotron Information Security Ltd., a corporation organized under the laws of Israel, and its subsidiaries, having its principal offices at 6 Galgaley Haplada Street, Herzliya 4672206 Israel (“Nyotron”), and the evaluator (the “Client”); Client and Nyotron shall be referred to each as a “Party” and collectively as the “Parties”). By clicking on the appropriate click-wrap section in the Nyotron website/platform you expressly acknowledge that you have read, understood and agree to be bound by the terms and conditions of this Agreement. In order to examine the possibility of future cooperation between the Parties and in order to enable Client to examine the Software (as defined below), the Parties agree as follows:
ATERNITY EVALUATION AGREEMENTEvaluation Agreement • March 13th, 2020 • Delaware
IMPORTANT: PLEASE READ BEFORE INSTALLATION OR USE OF ANY EVALUATION PRODUCTS (AS DEFINED BELOW). THIS ATERNITY EVALUATION AGREEMENT ("AGREEMENT") IS A BINDING AGREEMENT BETWEEN ATERNITY LLC ("ATERNITY") AND THE ENTITY OR COMPANY THAT IS THE AUTHORIZED USER OF THE EVALUATION PRODUCTS ("COMPANY"). BY DOWNLOADING, INSTALLING, ACCESSING OR IN ANY WAY USING THE EVALUATION PRODUCTS, COMPANY IS UNCONDITIONALLY CONSENTING TO BE BOUND BY AND IS BECOMING A PARTY TO THIS AGREEMENT WITH ATERNITY. IF COMPANY DOES NOT UNCONDITIONALLY AGREE TO ALL OF THE TERMS OF THIS AGREEMENT, COMPANY IS NOT AUTHORIZED TO AND MAY NOT DOWNLOAD, INSTALL, ACCESS OR USE ANY OF THE EVALUATION PRODUCTS.
Turner Evaluation AgreementEvaluation Agreement • March 12th, 2021 • New York
This Evaluation Agreement (this “Agreement”) is between the company (or other entity) that you represent (“Licensee”) and Paper Software LLC (“Paper Software”). You repre- sent that you are an agent of such company (or other entity) and that you have the authority to enter into this Agreement on behalf of such company (or other entity).
ACCEPTANCE OF THE TERMS OF THE EVALUATION AGREEMENT:Evaluation Agreement • August 18th, 2023
BY DOWNLOADING, INSTALLING, COPYING, ACCESSING, USING THE SOFTWARE AND/OR SIGNIFYING YOUR ACCEPTANCE TO THIS EVALUATION AGREEMENT (the "AGREEMENT"), YOU AGREE TO THE TERMS OF THIS ELECTRONIC AGREEMENT ON YOUR OWN BEHALF AND ON BEHALF OF THE LICENSEE LISTED IN THE ORDER AGREEMENT. YOU REPRESENT AND WARRANT THAT YOU HAVE FULL AUTHORITY TO BIND THE CLIENT TO THESE TERMS. IF YOU DO NOT AGREE TO THESE TERMS AND DO NOT HAVE THE AUTHORITY AS PROVIDED HEREIN, DO NOT DOWNLOAD, INSTALL, COPY, ACCESS, OR USE THE SERVICES AND SOFTWARE.]
Evaluation Agreement V7Evaluation Agreement • November 4th, 2023
Evaluation Criteria (Please detail the scope of the evaluation project and identify the objectives of the evaluation such as feature or functionality requirements for success.): POC scope is to deploy on internal environment. Malware testing, ease of deployment/management, and end user interoperability.
Evaluation AgreementEvaluation Agreement • September 13th, 2021 • New York
This Infor Subscription Software and Subscription Services Evaluation Agreement (the “Agreement”) is between Infor (US), Inc., a Delaware corporation with a principal place of business at 641 Avenue of the Americas, New York, NY 10011 (“Infor”) and your company (“Licensee”). This Agreement governs the use of any products or services made available by Infor hereunder, including Infor’s subscription software products (the “Subscription Software”) and any hosting or other services related to such Subscription Software (the “Subscription Services”). For purposes of clarity, Subscription Services do not include support services.
iNoCulator™ Evaluation AgreementEvaluation Agreement • June 19th, 2024 • California
This iNoCulator™ Evaluation Agreement is made and entered as of the Agreement Effective Date listed above by and between Signature and Evaluator (each individually a "Party" and collectively the "Parties"). The "Agreement" consists of this Preamble, the terms and conditions herein and other Exhibits or Attachments expressly referenced herein. In consideration of the mutual covenants and agreements hereinafter set forth, the Parties, intending to be legally bound, agree as follows:
HEALTH & COUNSELLINGEvaluation Agreement • November 20th, 2018
• fill out, sign, and submit two copies of your agreement to your tutorial leader by Jan. 18th (your tutorial leader will retain one, and return this green copy to you)
DENSIFY EVALUATION AGREEMENTEvaluation Agreement • July 12th, 2021 • Ontario
PLEASE READ THE FOLLOWING EVALUATION AGREEMENT CAREFULLY. BY CLICKING THE “AGREE” BUTTON AND PROCEEDING WITH THE EVALUATION FOR THE SERVICE, YOU, ON BEHALF OF THE COMPANY OR ORGANIZATION FOR WHOSE BENEFIT YOU ACT (“CUSTOMER”) ACKNOWLEDGE THAT YOU HAVE READ AND AGREE TO BE BOUND BY THE TERMS AND CONDITIONS AS DEFINED IN THE EVALUATION AGREEMENT (“AGREEMENT”) BETWEEN CUSTOMER AND CIRBA INC. D/B/A DENSIFY (“DENSIFY”) (TOGETHER THE “PARTIES” AND INDIVIDUALLY A “PARTY”).
SemEval 2016: Abstract Meaning Representation Parsing Task Evaluation AgreementEvaluation Agreement • August 20th, 2015
User agrees on behalf of User’s Research Group, to receive media (CD-ROM, DVD, hard drive, web download, etc.), named below under "Corpora and/or Data Received," containing images, speech, text and/or video data from the Linguistic Data Consortium (LDC). User agrees to use the material received under this agreement (the “Data”) only for purposes of the SemEval 2016 Abstract Meaning Representation Parsing Task Evaluation at the geographic site indicated above. User and User’s Research Group may include limited excerpts from the Data in articles, reports and other documents describing the results of work performed in the SemEval 2016 Abstract Meaning Representation Parsing Task Evaluation. User further agrees not to otherwise publish, retransmit, disclose, display, copy, reproduce or redistribute the Data to others outside of User’s Research Group.
EVALUATION AGREEMENTEvaluation Agreement • March 6th, 2018 • New York
This Evaluation Agreement (The “Agreement”), is by and between Infor (US), Inc., a Delaware corporation with a place of business located at 40 General Warren Blvd. Ste. 110, Malvern, PA 19355 (“Infor”) and the entity accepting this Agreement (“Licensee”) (individually a “Party” and collectively the “Parties”). This Agreement shall be effective the date Licensee obtains access to the Product (“Agreement Effective Date”) and shall continue in effect for thirty (30) days (the “Evaluation Period”).
NVIDIA Model Evaluation AgreementEvaluation Agreement • October 1st, 2024 • Delaware
This Evaluation Agreement (“Agreement”) is a legal agreement by and between NVIDIA Corporation, a Delaware corporation, on behalf of itself and its affiliates ("NVIDIA") and you, whether an individual or entity (“you” or “your”). NVIDIA and you are each a “party” and collectively the “parties.” This Agreement governs the use of certain NVIDIA artificial intelligence models, including software, checkpoints, learnt weights, algorithms, parameters, configuration files, datasets and documentation, if and when available (collectively, the “Licensed Materials”) that NVIDIA delivers to you under this Agreement.
Sample Letter upon Agreement to Provide the Requested EvaluationEvaluation Agreement • May 21st, 2020
Thank you for agreeing to evaluate ______________, _____________Professor of _____________, who is being considered for promotion to __________________________at the University of Oregon. As part of our promotion process, we seek outside evaluations from highly regarded faculty members in the candidate’s field to help us assess the candidate’s scholarly contributions to the field. When you submit your evaluation–by September 16, 202_, as previously agreed–please also provide a copy of your current curriculum vita or biographical sketch, which we will provide to the University’s personnel committees.
CoNLL 2016 Evaluation AgreementEvaluation Agreement • January 13th, 2016
User agrees on behalf of User’s Research Group, to receive media (CD-ROM, DVD, hard drive, web download, etc.), named below under "Corpora and/or Data Received," containing images, speech, text and/or video data from the Linguistic Data Consortium (LDC). User agrees to use the material received under this agreement (the “Data”) only for purposes of the CoNLL 2016 Shared Task on Multilingual Shallow Discourse Parsing (the “2016 Shared Task”) at the geographic site indicated above. User and User’s Research Group may include limited excerpts from the Data in articles, reports and other documents describing the results of work performed in the 2016 Shared Task. User further agrees not to otherwise publish, retransmit, disclose, display, copy, reproduce or redistribute the Data to others outside of User’s Research Group.
SampleSafeTM Evaluation AgreementEvaluation Agreement • May 2nd, 2014
The 30-day evaluation period begins on the date of delivery of the evaluation unit. Under certain circumstances, Drucker Diagnostics may offer an extension to this period. Requests for extension must be submitted in writing (including email) before the expiration of the evaluation period, and approved by Drucker Diagnostics to be considered valid.
